Virtu KCG Holdings’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-863
Closed -$94K – 3208
2016
Q4
$94K Buy
+863
New +$94.5K ﹤0.01% 2931
2016
Q3
– Sell
-657
Closed -$60K – 3114
2016
Q2
$60K Buy
+657
New +$57.2K ﹤0.01% 2640
2016
Q1
– Sell
-1,001
Closed -$112K – 2918
2015
Q4
$112K Buy
+1,001
New +$136K ﹤0.01% 2964

Other funds holding CTSO

Virtu KCG Holdings's CTSO Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Cytosorbents (CTSO) in Q1 2017, closing a stake of 863 shares — an estimated $94K sold.

Virtu KCG Holdings first reported a position in CTSO in Q4 2015 and held it in 3 quarters. The position peaked at $112K in Q4 2015. 37 funds tracked by Wall St. Rank hold CTSO as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Cytosorbents position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 863 Cytosorbents shares in Q1 2017, an estimated $94K.
  • Virtu KCG Holdings first reported a position in Cytosorbents in Q4 2015 and held it in 3 quarters.
  • Virtu KCG Holdings's Cytosorbents position peaked at $112K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Cytosorbents as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.